Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic Cancer

Name: Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic Cancer
Published: 2020
License: Public Domain

M.D. Anderson Cancer Center · 2020

ClinicalTrials.gov · Datasets · License: Public Domain · 2020

Open Source ↗

advanced malignant neoplasm, colorectal carcinoma metastatic in the liver, metastatic malignant neoplasm in the liver, refractory malignant neoplasm, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic Cancer

Related documents